Modifiable Lifestyle Factors as Effect Modifiers of Diet-Induced Changes in the Physical and Psychological Impacts of Multiple Sclerosis: A Secondary Analysis of the WAVES Trial
Sclerosis · 23.03.2026 · 4 (1) · 7
DOI: 10.3390/sclerosis4010007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sclerosis, online erschienen am 23.03.2026. Verfasst von Lauren R. Berry und 8 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Multiple Sclerosis Society, University of Iowa institutional funds, and the National Center for Advancing Translational Sciences of the National Institutes of Health, University of Iowa Fraternal Order of Eagles Diabetes Research Center.
Abstract (Originalsprache)
Background/Objectives: Evidence suggests that modifiable lifestyle interventions improve disability in relapsing multiple sclerosis (MS); however, interactions between different factors may impact outcomes. Thus, the objective of this secondary analysis was to investigate diet-induced effects on the impact of MS and effect modification by other modifiable lifestyle factors.
Methods
The physical and psychological impact of MS was assessed with the MS Impact Scale-29 (MSIS) at run-in, baseline, 12 weeks, and 24 weeks. Participants were randomized at baseline to the Swank low-saturated fat or Wahls modified Paleolithic elimination diets and instructed to maintain usual physical activity, objectively measured with an accelerometer, throughout the trial. Baseline information on sleep, physical activity, alcohol, and smoking was explored as effect modifiers.
Results
Among the Swank group, MSIS-Physical scores improved from 33.8 ± 3.8 at baseline to 28.7 ± 3.6 at 12 weeks (p = 0.04) and 25.3 ± 3.5 at 24 weeks (p < 0.001). MSIS-Psychological scores also improved from 35.7 ± 3.3 at baseline to 25.6 ± 2.6 at 12 weeks (p = 0.001) and 22.8 ± 2.4 at 24 weeks (p < 0.001). Among the Wahls group, MSIS-Physical scores improved from 33.8 ± 3.1 at baseline to 21.7 ± 3.0 at 12 weeks (p < 0.001) and 19.0 ± 3.1 at 24 weeks (p < 0.001). MSIS-Psychological scores also improved from 38.4 ± 3.8 at baseline to 25.5 ± 3.8 at 12 weeks (p < 0.001) and 20.6 ± 3.6 at 24 weeks (p < 0.001). Improvements in MSIS-Physical were greater among participants who were physically inactive or drank little alcohol at baseline.
Conclusions
Both diets led to favorable within-group improvements in the perceived impact of MS. People with MS who are physically inactive or drink little alcohol may benefit the most from dietary interventions.
Förderung
- National Multiple Sclerosis Society
- University of Iowa institutional funds, and the National Center for Advancing Translational Sciences of the National Institutes of Health
- University of Iowa Fraternal Order of Eagles Diabetes Research Center
- Carter Chapman Shreve Family Foundation and the Carter Chapman Shreve Fellowship Fund
- University of Iowa College of Public Health Preventive Intervention Center
Zitieren
APA
Berry, L. R., Titcomb, T. J., Shemirani, F., Eyck, P. T., Carr, L. J., Darling, W. G., Hoth, K. F., Snetselaar, L. G., & Wahls, T. L. (2026). Modifiable Lifestyle Factors as Effect Modifiers of Diet-Induced Changes in the Physical and Psychological Impacts of Multiple Sclerosis: A Secondary Analysis of the WAVES Trial. Sclerosis, 4(1), 7. https://doi.org/10.3390/sclerosis4010007
Vancouver
Berry LR, Titcomb TJ, Shemirani F, Eyck PT, Carr LJ, Darling WG, et al. Modifiable Lifestyle Factors as Effect Modifiers of Diet-Induced Changes in the Physical and Psychological Impacts of Multiple Sclerosis: A Secondary Analysis of the WAVES Trial. Sclerosis. 2026;4(1):7. doi:10.3390/sclerosis4010007
BibTeX
@article{Berry2026,
author = {Berry, Lauren R. and Titcomb, Tyler J. and Shemirani, Farnoosh and Eyck, Patrick Ten and Carr, Lucas J. and Darling, Warren G. and Hoth, Karin F. and Snetselaar, Linda G. and Wahls, Terry L.},
title = {Modifiable Lifestyle Factors as Effect Modifiers of Diet-Induced Changes in the Physical and Psychological Impacts of Multiple Sclerosis: A Secondary Analysis of the WAVES Trial},
journal = {Sclerosis},
year = {2026},
volume = {4},
number = {1},
pages = {7},
doi = {10.3390/sclerosis4010007}
}
EUVIMED